Finland· FI-REL-REL8269

Cosaldon Retard

A pentifylline product, registered in Finland by HOECHST.

ATC C04AD01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCosaldon RetardATCC04AD01REGISTER NO.FI-REL-REL8269PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
HOECHST
Country
Finland (FI)
ATC code
C04AD01
ATC class
Pentifylline
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C04AD01

Pentifylline, as other registers publish it.

All pentifylline products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/276db4f5-488e-40c0-9845-8d1c3ce6b79d
GET /v1/drugs/276db4f5-488e-40c0-9845-8d1c3ce6b79d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "depottabletti",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "pentifylliini",
  "ma_number": "6368",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL8269",
  "authorised_at": "1972-04-12"
}

See everything about pentifylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.